People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Denver Health’s Outpatient Behavioral Health Services opened the first naloxone vending machine on its campus.

Here are some of the coolest things Israeli researchers have sniffed out about the underappreciated sense of smell.

Many people with depression and anxiety in the U.S. could benefit from medication but do not receive any treatment, ...

At least two people have died and dozens more Kansas residents are being treated for symptoms in what health officials are ...

The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few ...

How can you make therapy work best for you? Here are a few tips. And a new study offers more evidence that teens are in trouble.